Top 17 Atea Pharmaceuticals investors
The most complete profiles first. Showing 17 of 17.
Annie MitsakVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Verified email available
Andrew PangVerified
Venture Capital, Private Equity Firm · Hong Kong
Health CareGeneticsWomen FoundedLife SciencePortfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more
Verified email available
AnneVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Verified email available
Catherine PoulinVerified
Private Equity Firm, Investment Partner · Canada
Health CareInvestment ManagementLife ScienceEmerging MarketsPortfolio: HighLife, CurvaFix, Aprea, F2G and 19 more
Verified email available
Paulina HillVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Verified email available
Rob FaulknerVerified
Hedge Fund, Venture Capital, Private Equity Firm · United States
Health CareHospitalsGeneticsWomen FoundedPortfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more
Contact details available
Francesco Draetta
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Contact details available
Katie Kerfoot
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Contact details available
Michelle Doig
Venture Capital, Investor · Canada
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Contact details available
Alain J. Gilbert
Private Equity Firm, Investment Partner · France
Health CareInvestment ManagementLife ScienceEmerging MarketsPortfolio: HighLife, CurvaFix, Aprea, F2G and 19 more
Contact details available
Barney Han
Venture Capital, Private Equity Firm
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more
Contact details available
Charles Chon
Venture Capital, Private Equity Firm · Hong Kong
Health CareGeneticsWomen FoundedLife SciencePortfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more
Contact details available
Gerard van Hamel Platerink
Hedge Fund, Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more
Contact details available
Marc
Private Equity Firm, Investment Partner · Canada
Health CareInvestment ManagementLife ScienceEmerging MarketsPortfolio: HighLife, CurvaFix, Aprea, F2G and 19 more
Contact details available
Reese Yeh
Venture Capital, Private Equity Firm
Health CareGeneticsWomen FoundedLife SciencePortfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more
Contact details available
Tinnie Chau, CFA
Venture Capital, Private Equity Firm
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: Goldfinch Biopharma, Syros Pharmaceuticals, Vida Health, xInnovent Biologics and 34 more
Contact details available
Andrew Hack, MD, PhD
Venture Capital, Private Equity Firm, Angel/Individual · United States
SeedLife ScienceBiotechnologyFinTechHealth DiagnosticsPortfolio: Xilio Therapeutics, Affinivax, JenaValve Technology, Atea Pharmaceuticals and 1 more
Contact details available
Frequently asked questions
How many Atea Pharmaceuticals investors are on Angel Roster?
Angel Roster lists 17 Atea Pharmaceuticals investors. 5 of them (29%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (14), Private Equity Firms (11) and Investment Partner Investors (4). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Atea Pharmaceuticals investors invest in?
Among those that list a stage, the most common are Seed (5).
Where are Atea Pharmaceuticals investors based?
Most are based in the United States (8), Canada (3) and Hong Kong (2).
Which companies have Atea Pharmaceuticals investors backed?
The most-backed portfolio companies among them are Nuvation Bio (13), Syros Pharmaceuticals (13), Checkmate Pharmaceuticals (9), Attenua (8) and Beam Therapeutics (8).
How do I contact Atea Pharmaceuticals investors?
Create a free Angel Roster account to search and filter all 17, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.